Kuros: MagnetOs Builds Sales; the Cash Label Needs Precision

Kuros Biosciences AG 's first-half numbers show a business growing quickly enough to attract attention well beyond the orthobiologics aisle. They also demonstrate why an appealing liquidity headline needs to be unpacked before it is repeated in a board presentation.